Overview
Losartan and Memory
Status:
Completed
Completed
Trial end date:
2022-03-31
2022-03-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study investigates the effect of a single dose of 50mg losartan vs placebo on BOLD signal during memory encoding.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of OxfordTreatments:
Losartan
Criteria
Inclusion Criteria:- willing and able to provide informed consent
- male or Female, aged 18-50 years
- body mass index (BMI) of 18-30 kg/m2
- non- or light-smoker (< 5 cigarettes a day)
- STAIT score of at least 40
Exclusion Criteria:
- Female participant who is pregnant or breast-feeding
- CNS-active medication during the last 6 weeks
- Current blood pressure or other heart medication (especially aliskiren or beta
blockers)
- Diagnosis of intravascular fluid depletion or dehydration
- Past or present DSM-IV axis-I diagnosis or suspected diagnosis (from SCID results at
screening)
- Alcohol or substance abuse
- First-degree family member with a history of a severe psychiatric disease
- Impaired liver or kidney function
- Lifetime history of epilepsy or other neurological disease, systemic infection, or
clinically significant hepatic, cardiac, obstructive respiratory, renal,
cerebrovascular, metabolic, endocrine or pulmonary disease or disorder which, in the
opinion of the investigator, may either put the participants at risk because of
participation in the study, or may influence the result of the study, or the
participant's ability to participate in the study.
- High or moderate risk of coronavirus, based on the NHS checklist for coronavirus
vulnerability
https://www.nhs.uk/conditions/coronavirus-covid-19/people-at-higher-risk/whos-at-highe
r-risk-from-coronavirus/
- Contraindication to MRI (e.g. metal implant)
- Insufficient English skills
- participated in another study involving CNS-active medication during the last 6 weeks
Participants will also not be able to take part if they are left-handed, due to the
research MRI aspect of the study relying on group means.